A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients

被引:160
作者
Wang, AYM [1 ]
Wang, M [1 ]
Woo, J [1 ]
Law, MC [1 ]
Chow, KM [1 ]
Li, PKT [1 ]
Lui, SF [1 ]
Sanderson, JE [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
glomerular filtration rate; cardiac mass; uremia; end-stage renal failure; CAPD; cardiovascular disease; dialysis;
D O I
10.1046/j.1523-1755.2002.00471.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Left ventricular hypertrophy (LVH) and dialysis adequacy are both important predictors for mortality in dialysis patients. This study evaluated the association between residual renal function (RRF) and the severity of LVH in endstage renal failure (ESRF) patients undergoing long-term continuous ambulatory peritoneal dialysis (CAPD). Methods. A cross-section study was performed with left ventricular mass index (LVMi), determined in 158 non-diabetic CAPD patients using echocardiography and its relationship with residual glomerular filtration rate (GFR), peritoneal dialysis (PD) and total weekly urea clearance (Kt/V) and other known risk factors for LVH was evaluated. Results. Twelve patients had no LVH (group I). The remaining 146 patients were stratified [group II (lowest), III and IV (highest)] according to the LVMi (median 207 g/m(2) ; range 103 to 512 g/m(2)). Across the four groups of patients with increasing LVMi, there was significant decline in GFR (2.27 +/- 1.98 vs. 1.49 +/- 1.58 vs. 1.61 +/- 1.91 vs. 0.80 +/- 1.42 mL/min/1.73 m(2) ; P = 0.011) and total weekly Kt/V (1.98 +/- 0.44 vs. 1.96 +/- 0.38 vs. 1.92 +/- 0.42 vs. 1.71 +/- 0.42; P = 0.037); however, PD Kt/V was similar for all four groups. Patients with better-preserved residual GFR not only had significantly higher total Kt/V, but were less anemic and hypoalbuminemic and had a trend toward lower systolic blood pressure and arterial pulse pressure. Multiple regression analysis showed that other than age, gender, body weight, arterial pulse pressure, hemoglobin and serum albumin, known factors for LVH, residual GFR (estimated mean -7.94; 95% confidence interval -15.13 to -0.74; P = 0.031) was also independently associated with LVMi. Conclusions. Other than anemia, hypoalbuminemia and arterial pulse pressure, this study demonstrates an important, novel association between the degree of RRF and severity of LVH in ESRF patients undergoing long-term CAPD. Prospective studies are needed to define if indeed there is a cause-effect relationship between this association, to evaluate if a decline in residual GFR is independently associated with an increase in LVMi, and to determine whether treatment directed at preserving RRF will reduce the severity of LVH, improve cardiac performance and hence survival of these patients.
引用
收藏
页码:639 / 647
页数:9
相关论文
共 48 条
  • [1] Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects
    Cannella, G
    Paoletti, E
    Delfino, R
    Peloso, G
    Rolla, D
    Molinari, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) : 659 - 664
  • [2] Churchill DN, 1996, J AM SOC NEPHROL, V7, P198
  • [3] SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    CONVERSE, RL
    JACOBSEN, TN
    TOTO, RD
    JOST, CMT
    COSENTINO, F
    FOUADTARAZI, F
    VICTOR, RG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1912 - 1918
  • [4] Peritoneal solute transport predicts survival on CAPD independently of residual renal function
    Davies, SJ
    Phillips, L
    Russell, GI
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (04) : 962 - 968
  • [5] What really happens to people on long-term peritoneal dialysis?
    Davies, SJ
    Phillips, L
    Griffiths, AM
    Russell, LH
    Naish, PF
    Russell, GI
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (06) : 2207 - 2217
  • [6] Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients
    Enia, G
    Mallamaci, F
    Benedetto, FA
    Panuccio, V
    Parlongo, S
    Cutrupi, S
    Giacone, G
    Cottini, E
    Tripepi, G
    Malatino, LS
    Zoccali, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) : 1459 - 1464
  • [7] Cardiac disease in diabetic end-stage renal disease
    Foley, RN
    Culleton, BF
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Murray, DC
    Barre, PE
    [J]. DIABETOLOGIA, 1997, 40 (11) : 1307 - 1312
  • [8] CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY
    FOLEY, RN
    PARFREY, PS
    HARNETT, JD
    KENT, GM
    MARTIN, CJ
    MURRAY, DC
    BARRE, PE
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (01) : 186 - 192
  • [9] Foley RN, 1996, J AM SOC NEPHROL, V7, P728
  • [10] DETERMINANTS OF LEFT-VENTRICULAR HYPERTROPHY AND SYSTOLIC DYSFUNCTION IN CHRONIC-RENAL-FAILURE
    GREAVES, SC
    GAMBLE, GD
    COLLINS, JF
    WHALLEY, GA
    SHARPE, DN
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) : 768 - 776